NeoChord, Inc. Appoints New Chief Executive Officer to Lead Commercialization Efforts and Study Novel First-Line Therapy for Mitral Valve Regurgitation
Maple GroveManufacturingBiotechnologyHealth CareMedicalMedical Device
Description
NeoChord appointed Todd Berg as Chief Executive Officer to oversee clinical and commercial programs for transeptal and transapical repair of damaged mitral valve chords resulting in regurgitation.
Company Information
Company
Neochord
Location
10900 73rd Avenue North, Suite 101
Maple Grove, Minnesota, United States
About
NeoChord is a privately held, medical technology company and the world-leader in beating heart delivery of artificial chords in the treatment of mitral valve regurgitation. The company is dedicated to advancing the treatment of mitral regurgitation and developing innovative therapies for degenerative mitral valve disease.
Fundz sees it the moment Neochord changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Maple GroveManufacturingBiotechnologyHealth CareMedicalMedical Device